|
1）Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403: 503-11
|
|
|
|
2）Davis RE, Ngo VN, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010; 463: 88-92
|
|
|
|
|
|
3）Lenz G, Davis RE, Ngo VN, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008; 319: 1676-9
|
|
|
|
|
|
4）Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009; 459: 712-6
|
|
|
|
|
|
5）Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappa B in diffuse large B-cell lymphoma. Nature. 2009; 459: 717-21
|
|
|
|
|
|
6）Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011; 470: 115-9
|
|
|
|
|
|
7）Iqbal J, Greiner TC, Patel K, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 2007; 21: 2332-43
|
|
|
|
|
8）Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 2006; 203: 311-7
|
|
|
|
|
|
9）Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008; 105: 13520-5
|
|
|
|
|
|
10）Schmidlin H, Diehl SA, Nagasawa M, et al. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood. 2008; 112: 1804-12
|
|
|
|
|
|
11）Iqbal J, Sanger WG, Horsman DE, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol. 2004; 165: 159-66
|
|
|
|
|
|
12）Iqbal J, Neppalli VT, Wright G, et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol. 2006; 24: 961-8
|
|
|
|
|
|
13）Shivapurkar N, Toyooka S, Toyooka KO, et al. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer. 2004; 109: 786-92
|
|
|
|
|
|
14）Pasqualucci L, Dominguez-Sola D, Chiarenza A, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011; 471: 189-95
|
|
|
|
|
|
15）Bereshchenko OR, Gu W, Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nature Genet. 2002; 32: 606-13
|
|
|
|
|
|
16）Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011; 476: 298-303
|
|
|
|
|
|
17）Wilker PR, Kohyama M, Sandau MM, et al. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat Immunol. 2008; 9: 603-12
|
|
|
|
|
|
18）Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Develop-ment. 2007; 134: 4131-40
|
|
|
|
|
|
19）Mullighan CG, Zhang J, Kasper LH, et al. CREBBP mutations in relapsed acute lympho-blastic leukaemia. Nature. 2011; 471: 235-9
|
|
|
|
|
|
20）Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lympho-blastic leukaemia. Nature. 2012; 481: 157-63
|
|
|
|
|
|
21）Morin RD, Johnson NA, Severson TM, et al. Somatic mutations altering EZH2(Tyr641)in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010; 42: 181-5
|
|
|
|
|
|
22）Sneeringer CJ, Scott MP, Kuntz KW, et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3(H3K27)in human B-cell lymphomas. Proc Natl Acad Sci U S A. 2010; 107: 20980-5
|
|
|
|
|
|
23）Dalgliesh GL, Furge K, Greenman C, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature. 2010; 463: 360-3
|
|
|
|
|
|
24）Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012; 482: 226-31
|
|
|
|
|
|
25）Wu G, Broniscer A, McEachron TA, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012; 44: 251-3
|
|
|
|
|